Molecular Mechanisms of Class Switch Recombination
Molecular Mechanisms of Class Switch Recombination
批准号:
8386894
负责人:
Frederick W. Alt
金额:
$40.08万
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-12-15 至 2014-02-28
关键词:
AddressAlanineAllergic DiseaseAntibodiesAntibody FormationAutoimmune DiseasesB lymphoid malignancyB-LymphocytesBiochemical GeneticsBiological AssayCancer EtiologyCellsChromosomal translocationChromosome PairingChromosomesComplexCytidine DeaminaseCytogeneticsDNADNA Double Strand BreakDNA RepairDNA SequenceDNA StructureDeaminationDiseaseDouble Strand Break RepairExonsExtrinsic asthmaFrequenciesG22P1 geneGene RearrangementGenesGeneticGenetic ModelsGenetic TranscriptionHeavy-Chain ImmunoglobulinsHigher Order Chromatin StructureIGH@ gene clusterIgEImmune systemImmunoglobulin Class SwitchingImmunoglobulin Joining RegionImmunoglobulin Somatic HypermutationImmunoglobulin Switch RecombinationImmunoglobulin Variable RegionImmunologic Deficiency SyndromesImmunologyIndiumLinkLymphomaMalignant NeoplasmsMediatingMethodsModificationMolecularMolecular ConformationMusMutant Strains MiceMutationNonhomologous DNA End JoiningOncogenesOutcomePathogenesisPathway interactionsPhosphorylationProcessProductionProteinsReagentRegulationReporterRoleSeriesSerineSingle-Stranded DNASiteSpecificityTestingTransgenic OrganismsVaccinesWorkYeastsZebrafishactivation-induced cytidine deaminasechromatin immunoprecipitationds-DNAendonucleasein vitro Assayin vivoinsightmutantnovelnovel strategiesprotein complexrepairedreplication factor Aresponse
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This application proposes studies of the mechanisms of immunoglobulin heavy chain (IgH) class switch
recombination (CSR) and Somatic Hypermutation (SHM). We have shown that Activation Induced Cytidine
Deaminase (AID), the initiator of CSR, is a single strand DNA (ssDNA) specific cytidine deaminase and we
employed a series of novel biochemical and genetic approaches to elucidate mechanisms by which AID gains
access to transcribed double strand (ds)DNA sequences in the context transcription-generated ssDNA
structures and/or certain AID modifications or co-factors. We also showed that CSR may employ general
processes for synapsis of AID-initiated DNA double strand breaks (DSBs), that general DNA repair factors
function in CSR, and that two distinct end-joining pathways fuse S region breaks to complete CSR. Our
current proposal builds on these observations in the context of three specific Aims. Our first aim proposes use
of biochemical and genetic approaches to elucidate basic mechanisms of AID function and regulation. In this
regard, we developed methods to purify AID from normal B cells, in vitro assays for transcription-dependent
AID deamination of dsDNA DNA, and genetic approaches to evaluate in vivo AID functions elucidated
biochemically. Our second aim addresses mechanisms by which DNA sequences influence AID activity and
its outcome. For these studies, we developed targeted mutation assays to replace endogenous IgH class
switch (S) regions and exons encoding IgH variable regions with test sequences that will allow us to determine
how substrate sequences influence activities of AID and other relevant factors in CSR and SHM. Together, the
complementary biochemical and genetic assays of Aims 1 and 2 offer a powerful approach for elucidating
factors and mechanisms involved in initiation and regulation of IgH CSR and SHM. A third proposed aim is to
elucidate processes involved in the repair of AID induced DSBs to complete CSR. For these studies, we again
have developed a large array of reagents and novel approaches, including cytogenetic methods to follow CSR
related breaks in chromosomes, novel genetic approaches to study factors involved in long range synapsis of
DSBs, and genetic models to elucidate DSB repair pathways that complete IgH CSR. Our proposed studies
should provide novel insights into the mechanism of antibody production via IgH CSR and, therefore, be
relevant to understanding immunodeficiencies, vaccine immunology, and autoimmune diseases. As CSR is
required for IgE production, the work will also be relevant to understanding pathogenesis of allergic diseases
and asthma. Finally, the work is relevant to B cell malignancies as they often involve chromosomal
translocations that link translocated oncogenes to IgH S regions via aberrant CSR.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of DNA Double Strand Break Response in Suppression of Thymic Lymphoma
-
批准号:7780950
-
项目类别:
-
资助金额:$44.71万
-
财政年份:2010
-
负责人:Frederick W. Alt
-
依托单位:
Mouse models of severe combined immunodeficiencies
-
批准号:7614101
-
项目类别:
-
资助金额:$47.73万
-
财政年份:2009
-
负责人:Frederick W. Alt
-
依托单位:
Mechanisms that Regulate Antibody Class Switch Recombination and Somatic Hypermutation
-
批准号:10392890
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:7743798
-
项目类别:
-
资助金额:$42.36万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
AID Targeting Mechanisms for IgH Switch Recombination and Somatic Hypermutation
-
批准号:9228317
-
项目类别:
-
资助金额:$44.25万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Mechanisms that Regulate Antibody Class Switch Recombination and Somatic Hypermutation
-
批准号:10612752
-
项目类别:
-
资助金额:$53.1万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:7577240
-
项目类别:
-
资助金额:$42.33万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:8197214
-
项目类别:
-
资助金额:$42.63万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
AID Targeting Mechanisms for IgH Switch Recombination and Somatic Hypermutation
-
批准号:8697880
-
项目类别:
-
资助金额:$43.85万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:7995253
-
项目类别:
-
资助金额:$42.23万
-
财政年份:2008
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanism of Translocations in B-Cell Lymphoma
-
批准号:7156133
-
项目类别:
-
资助金额:$40.2万
-
财政年份:2006
-
负责人:Frederick W. Alt
-
依托单位:
Role of H2AX and ATM in Suppression of Thymic Lymphomas
-
批准号:6989691
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2004
-
负责人:Frederick W. Alt
-
依托单位:
T Cell Development
-
批准号:6742737
-
项目类别:
-
资助金额:$0.87万
-
财政年份:2004
-
负责人:Frederick W. Alt
-
依托单位:
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
-
批准号:8220847
-
项目类别:
-
资助金额:$50.14万
-
财政年份:2003
-
负责人:Frederick W. Alt
-
依托单位:
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
-
批准号:8444354
-
项目类别:
-
资助金额:$45.76万
-
财政年份:2003
-
负责人:Frederick W. Alt
-
依托单位:
Towards a Mouse Model of Classical Hodgkin's Disease and PTLD
-
批准号:8029601
-
项目类别:
-
资助金额:$49.01万
-
财政年份:2003
-
负责人:Frederick W. Alt
-
依托单位:
ROLE OF VAV AND ITS EFFECTORS IN LYMPHOCYTE ACTIVATION
-
批准号:6496054
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2001
-
负责人:Frederick W. Alt
-
依托单位:
ROLE OF VAV AND ITS EFFECTORS IN LYMPHOCYTE ACTIVATION
-
批准号:6346235
-
项目类别:
-
资助金额:$42.66万
-
财政年份:2000
-
负责人:Frederick W. Alt
-
依托单位:
MURINE MODELS OF SEVERE COMBINED IMMUNODEFICIENCIES
-
批准号:6332448
-
项目类别:
-
资助金额:$27.63万
-
财政年份:2000
-
负责人:Frederick W. Alt
-
依托单位:
Molecular Mechanisms of Class Switch Recombination
-
批准号:6344608
-
项目类别:
-
资助金额:$18.51万
-
财政年份:2000
-
负责人:Frederick W. Alt
-
依托单位:
海外基金